Biodexa Pharmaceuticals

BDRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.80

-$0.63 (-18.37%)

At close: Nov 2, 2026, 4:00 PM ET

$2.80

$0.00 (0.00%)

After-hours: Nov 2, 2026, 4:34 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Cash & Equivalents	8.52M	1.67M	5.97M	2.84M	10.06M	7.55M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	221.61K	715K	704K	329K	33K	95K
Inventory	n/a	n/a	-704K	n/a	n/a	n/a
Other Current Assets	n/a	n/a	704K	1.15M	1.06M	1.38M
Total Current Assets	12.42M	8.81M	7.03M	4.69M	11.76M	9.28M
Property-Plant & Equipment	90.84K	324K	571K	831K	1.15M	542K
Goodwill & Intangibles	5.64M	5.65M	2.94M	6K	n/a	n/a
Total Long-Term Assets	5.73M	5.97M	3.51M	837K	1.15M	542K
Total Assets	18.15M	14.78M	10.54M	5.53M	12.91M	9.82M
Account Payables	97K	707K	314K	339K	485K	337K
Deferred Revenue	570K	1.47M	n/a	197K	n/a	68K
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	107K
Other Current Liabilities	3.47M	921K	4.23M	386K	664K	1.62M
Total Current Liabilities	6.12M	5.03M	5.57M	1.9M	1.84M	2.99M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	643.87K	1.31M	n/a	n/a	-469	50K
Total Long-Term Liabilities	643.87K	1.42M	295K	463K	619.53K	110K
Total Liabilities	6.76M	6.46M	5.86M	2.36M	2.46M	3.1M
Total Debt	60.89K	727K	464K	624K	766K	260K
Book Value	11.38M	8.32M	4.68M	3.16M	10.45M	6.72M
Book Value Per Share	0.42	3.36	29.62	1.28K	5.19K	6.27K
Common Stock	14.07M	6.69M	1.19M	108.34K	98.47K	63K
Retained Earnings	-102.62M	-150.42M	-144.77M	-135.34M	-127.8M	-122.43M
Comprehensive Income	1.19M	53M	61.52M	53M	53M	54.72M
Shareholders Equity	11.38M	8.32M	4.68M	3.16M	10.45M	6.72M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a